Urinary nerve growth factor and brain-derived neurotrophic factor levels in children with lower urinary tract symptom

Urinary nerve growth factor and brain-derived neurotrophic factor levels in children with lower urinary tract symptom - Urinary NGF and BDNF in children with lower urinary tract symptom

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020390

Enrollment

100

Registered

2015-12-28

Start date

2013-09-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurogenic bladder, lower urinary tract symptom, nocturnal enuresis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with nocturnal enuresis and/or lower urinary tract symptom before treatments

Exclusion criteria

Exclusion criteria: Patients with underlying pathologic conditions such as renal, endocrine, metabolic, neurological disorders, urinary tract infection and malignant tumor

Design outcomes

Primary

Measure	Time frame
To identify the urinary biomarker which correlates with dysfunctional voiding sympton scores.	—

Secondary

Measure	Time frame
Urinary NGF and BDNF before the treatment, 12 weeks after the treatment, and after the treatment	—

Countries

Japan

Contacts

Public ContactKatsuya Aoki

Nara Medical University Department of Urology

aokik@naramed-u.ac.jp0744-22-3051

Outcome results